Inhibitor of dna methylation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) C07H 19/06 (2006.01) C07H 21/00 (2006.01)

Patent

CA 2454147

Zebularine has hypomethylating activity, and can be used to inhibit, reverse, and/or reduce DNA methylation in vivo and in vivo. Methods are provided for treating methylation-linked conditions through the application of 2- pyrimidinone derivatives, such as Zebularine. Compositions, including pharmaceutical compositions, comprising such derivatives are also provided. Also provided are kits for use in inhibiting DNA methylation, which kits include an amount of a 2-pyrimidinone derivative.

La zébularine présente une activité d'hypométhylation et peut être utilisée pour inhiber, inverser, et/ou réduire la méthylation in vivo et in vitro d'ADN. L'invention concerne des procédés permettant de traiter des états associés à la méthylation par l'application de dérivés de 2-pyrimidinone, tels que la zébularine. L'invention concerne également des compositions, notamment des compositions pharmaceutiques, comprenant lesdits dérivés. L'invention concerne en outre des kits destinés à être utilisés pour inhiber la méthylation d'ADN, lesdits kits contenant une certaine quantité de dérivé de 2-pyrimidinone.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitor of dna methylation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitor of dna methylation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitor of dna methylation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1610533

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.